請問能幫忙翻譯下這檢查報告嗎 感恩

PURPOSE AND INDICATION

Diagnosis, Staging, Treatment Planning

CLINICAL HISTORY:

1.2013-08-25 Lymph node, right neck, excision, carcinoma, metastatic.

2. Relevant treatment: Chemotherapy (none); Radiotherapy (none)

PROCEDURES:

1. Radionuclide: F-18 FDG, 18.44 mCi, IV injection

2. Scanning range: Whole body (head to upper thigh)

3. Non-diagnostic CT (no intravenous contrast) of PET/CT; Attenuation correction and anatomic localization.

4. Initial scan time after FDG injection: 59 minutes.

5. Delayed scan time after FDG injection: 119 minutes

6. Blood Glucose: 120 mg/dL.

FINDINGS:

I. Physiologic FDG activity: Brain, renal pelvis and urinary bladder.

II. Abnormal lesions:

1. Nasopharynx: Posterior region (initial SUVmax = 7.5, delayed initial SUVmax = 9.7)

2. Left level II Lymph nodes of neck (initial SUVmax = 2.1, delayed initial SUVmax = 3.1)

3. Right level II/V Lymph nodes of neck (initial SUVmax = 2.7, delayed initial SUVmax = 5.4)

IMPRESSIONS:

1. Indeterminate nature of hypermetabolic lesion involving posterior region of nasopharynx (D.D.: inflammatory/infectious process, malignancy, treatment effect, etc.) Further evaluation with clinical findings and histopathologic examination is suggested to ascertain the nature of aforementioned lesion as clinically indicated.

2. Left level II Lymph nodes of neck are suggestive of metastatic lymphadenopathy (D.D.: reactvie lymphadenopathy)

3. Right level II/V Lymph nodes of neck are in accord with pathology-proved malignancy (metastatic lymphadenopathy) and/or recent surgical effect.

Suggestions:

Histopathologic examination, correlation with and close follow-up by molecular and anatomical imaging (e.g., FDG PET/CT) are suggested to ascertain the nature of aforementioned lesions as clinically indicated.

Update:

拜託麻煩不要用翻譯軟體 是真的看的懂醫院報告的 人命關天 謝謝 感恩

1 Answer

Rating
  • 宏洺
    Lv 4
    8 years ago
    Favorite Answer

    目的和指示

    診斷,分期,治療計劃;

    臨床病史:

    1.2013-08-25的淋巴結,右頸部,切除,癌,轉移性。

    2。有關治療:化療(無);放療(無)

    程序:

    1。放射性核素檢查:F-18 FDG,18.44 MCI,靜脈注射

    2。掃描範圍:全身(頭到大腿上部)

    3。非診斷沒有靜脈造影CT(PET/ CT);衰減校正和解剖定位。

    4。葡萄糖注射液後的初始掃描時間:59分鐘。

    5。葡萄糖注射液後延遲掃描時間:119分鐘

    6。血糖:120毫克/分升。

    調查結果:

    一,生理性FDG活動:腦,腎盂和膀胱。

    二。異常的病變:

    1。鼻咽部:後區(初始SUVmax值=7.5,延遲SUVmax值=9.7)

    2。左二級頸部的淋巴結腫大(​​初始SUVmax值=2.1,延遲初始SUVmax值= 3.1)

    3。右II級/ V頸部的淋巴結腫大(初始SUVmax值=2.7,延遲SUVmax值=5.4)

    印象:

    1。建議不定高代謝病灶性質涉及鼻咽後區(DD:炎症/感染過程,惡性腫瘤,治療效果等),臨床所見和病理組織學檢查進一步評估,以確定上述病變性質,為臨床指徵。

    2。左二級頸部淋巴結轉移性淋巴結腫大提示(DD:reactvie的淋巴結腫大)

    3。右II級/ V頸部淋巴結病理證實的惡性腫瘤淋巴結轉移和/或最近手術效果符合。

    建議:

    組織病理學檢查,相關和密切隨訪分子和解剖成像(如FDG PET / CT)建議,以確定上述病變性質的臨床指徵。

    Source(s): 自己+參考翻譯
Still have questions? Get your answers by asking now.